Application no. and date | 15802075.0 (espacenet) (Federated) (European Patent Register), 20151130 | Patent/reg. no. and date | DK/EP 3227294, 20190814 | Publication date | 20171011 | Priority no. and date | US 201462085722 P, 20141201, US 201562166808 P, 20150527 | EP pub. no. and date |
EP 3227294 20171011 | Effective date | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | Applicant ref. no. | 1495982 | Inventor | INGHARDT, Tord Bertil, AstraZeneca
S-431 83 Mölndal, SE, TOMKINSON, Nicholas, AstraZeneca Alderley Park
Macclesfield Cheshire SK10 4TG, GB, GAN, Li-Ming, AstraZeneca
S-431 83 Mölndal, SE, STONEHOUSE, Jeffrey, Paul, c/o AstraZeneca Intellectual Property AstraZeneca 35 Gatehouse Drive Waltham
MA 02451, US, JOHANNESSON, Petra, AstraZeneca
S-431 83 Mölndal, SE, JURVA, Ulrik, AstraZeneca
S-431 83 Mölndal, SE, LINDSTEDT-ALSTERMARK, Eva-Lotte, AstraZeneca
S-431 83 Mölndal, SE, MICHAELSSON, Erik, AstraZeneca
S-431 83 Mölndal, SE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61P 9/10 (2006.01) , C07D 487/04 (2006.01) | Title | 1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONER SOM INHIBITORER AF MYELOPEROXIDASE | Int. application no. | EP2015077998 | Int. publication no. | WO2016087338 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|